Skip to main content
SpringerLink
Log in

Somatostatin analogues in the prevention of pancreas-related complications after pancreatic resection

  • Published:
Journal of Hepato-Biliary-Pancreatic Surgery

Abstract

Background/Purpose

The Achilles' heel of operative pancreatectomies is the pancreaticoenterostomy for proximal resections and the pancreatic parenchymal closure for distal resections. Inhibition of pancreatic exocrine secretions by somatostatin analogues has been suggested to decrease pancreas-specific complications, but this topic remains controversial.

Methods

We performed a randomized, prospective, placebo-controlled, multicenter trial of the use of perioperative vapreotide, a potent somatostatin analogue, in pancreatic resections for presumed neoplasms in 381 patients without chronic pancreatitis. We also reviewed the literature on the use of somatostatin and its analogues after pancreatectomy.

Results

When compared to the placebo, perioperative vapreotide had no effect on overall pancreas-specific complications (30.4% vs 26.4%), mortality (0% vs 1.4%), overall complications (40% vs 42%), and duration of hospitalization; there were no differences in complications per type of resection with use of vapreotide — proximal versus distal resection. Seven other prospective, randomized trials provide differing results.

Conclusions

Our study with vapreotide failed to show any benefit when administered perioperatively (and for 7 days postoperatively) on pancreas-specific complications after major pancreatectomy in patients without chronic pancreatitis. The use of perioperative analogues that suppress pancreatic exocrine secretion seems not to be warranted as routine treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. AO Whipple (1941) ArticleTitleThe rationale of radical surgery for cancer of the pancreas and ampullary region Ann Surg 114 612–5 Occurrence Handle17857897 Occurrence Handle1:STN:280:DC%2BD2srkt12ltQ%3D%3D

    PubMed  CAS  Google Scholar 

  2. CJ Yeo JL Cameron KD Lillemoe TA Sohn KA Campbell PK Sauter et al. (2002) ArticleTitlePancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized control trial evaluating survival, morbidity, and mortality Ann Surg 236 355–68 Occurrence Handle12192322 Occurrence Handle10.1097/00000658-200209000-00012

    Article  PubMed  Google Scholar 

  3. JJ Cullen MG Sarr DM Ilstrup (1994) ArticleTitlePancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management Am J Surg 168 295–8 Occurrence Handle7524375 Occurrence Handle1:STN:280:DyaK2M%2FjtVWksg%3D%3D Occurrence Handle10.1016/S0002-9610(05)80151-5

    Article  PubMed  CAS  Google Scholar 

  4. JH Balcom DW Rattner AL Warshaw Y Chang C Fernandez-del Castillo (2001) ArticleTitleTen-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization Arch Surg 136 391–8 Occurrence Handle11296108 Occurrence Handle10.1001/archsurg.136.4.391

    Article  PubMed  Google Scholar 

  5. C Gouillat JF Gigot (2002) ArticleTitlePancreatic surgical complications — the case for prophylaxis Gut 49 32–9

    Google Scholar 

  6. A Stojadinovic A Brooks A Hoos DP Jaques KC Conlon MF Brennan (2003) ArticleTitleAn evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma J Am Coll Surg 196 954–64 Occurrence Handle12788434 Occurrence Handle10.1016/S1072-7515(03)00010-3

    Article  PubMed  Google Scholar 

  7. SM Strasberg JA Drebin NA Mokadam DW Green KL Jones JP Ehlers D Linehan (2002) ArticleTitleProspective trial of a blood supply-based technique of pancreaticojejunostomy: effect on anastomotic failure in the Whipple procedure J Am Coll Surg 194 746–58 Occurrence Handle12081065 Occurrence Handle10.1016/S1072-7515(02)01202-4

    Article  PubMed  Google Scholar 

  8. M Buchler H Friess I Klempa P Hermanek U Sulkowski H Becker et al. (1992) ArticleTitleRole of octreotide in the prevention of postoperative complications following pancreatic resection Am J Surg 163 125–31 Occurrence Handle1733360 Occurrence Handle1:STN:280:DyaK387isFKjtg%3D%3D Occurrence Handle10.1016/0002-9610(92)90264-R

    Article  PubMed  CAS  Google Scholar 

  9. B Suc S Msika A Fingerhut G Fourtanier JM Hay F Holmieres et al. (2003) ArticleTitlethe French Associations for Surgical Research. Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intra-abdominal complications after pancreatic resection: prospective randomized trial Ann Surg 237 57–65 Occurrence Handle12496531 Occurrence Handle10.1097/00000658-200301000-00009

    Article  PubMed  Google Scholar 

  10. CJ Yeo JL Cameron MM Maher PK Sauter ML Zahurak MA Talamini et al. (1995) ArticleTitleA prospective randomised trial of pancreatico-gastrostomy and pancreaticojejunostomy after pancreaticoduodenectomy Ann Surg 222 580–8 Occurrence Handle7574936 Occurrence Handle1:STN:280:DyaK28%2FisFWhtQ%3D%3D

    PubMed  CAS  Google Scholar 

  11. K Tran C van Eijck V Di Carlo WC Hop A Zerbi G Balzano H Jeekel (2002) ArticleTitleOcclusion of the pancreatic duct versus pancreaticojejunostomy: a prospective randomized trial Ann Surg 236 422–8 Occurrence Handle12368670 Occurrence Handle10.1097/00000658-200210000-00004

    Article  PubMed  Google Scholar 

  12. I Klempa U Schwedes KH Usadel (1979) ArticleTitleVerhutung von postoperativen pankreatitischen koomplikationen nach duodenopankreatetomie durch somatostatin Chirurgia 50 427–31 Occurrence Handle1:CAS:528:DyaE1MXltlClt7s%3D

    CAS  Google Scholar 

  13. F Buccoliero GC Pansini F Mascoli C Mari A Donini G Navarra (1992) ArticleTitleSomatostatin in duodenocephalopancreatectomy for neoplastic pathology Minerva Chir 47 713–6 Occurrence Handle1351276 Occurrence Handle1:STN:280:DyaK383ptlKgtw%3D%3D

    PubMed  CAS  Google Scholar 

  14. A Beguiristain A Espi E Balen F Pardo JL Hernandez Lizoain J Alvarez Cienfuegos (1995) ArticleTitleSomatostatin prophylaxis following cephalic duodenopancreatectomy Rev Esp Enferm Dig 87 221–4 Occurrence Handle7742052 Occurrence Handle1:STN:280:DyaK2M3mtVGntQ%3D%3D

    PubMed  CAS  Google Scholar 

  15. C Gouillat J Chipponi J Baulieux C Partensky J Saric B Gayet (2001) ArticleTitleRandomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy Br J Surg 88 1456–62 Occurrence Handle11683740 Occurrence Handle1:STN:280:DC%2BD3MngvF2ntg%3D%3D Occurrence Handle10.1046/j.0007-1323.2001.01906.x

    Article  PubMed  CAS  Google Scholar 

  16. YS Shan ED Sy PW Lin (2003) ArticleTitleRole of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomized, controlled trial World J Surg 27 709–14 Occurrence Handle12732998 Occurrence Handle10.1007/s00268-003-6693-5

    Article  PubMed  Google Scholar 

  17. P Pederzoli C Bassi M Falconi MG Camboni (1994) ArticleTitleEfficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group Br J Surg 81 265–9 Occurrence Handle8156354 Occurrence Handle1:STN:280:DyaK2c3gslOmsw%3D%3D

    PubMed  CAS  Google Scholar 

  18. M Montorsi M Zago F Mosca L Capussotti E Zotti G Ribotta et al. (1995) ArticleTitleEfficacy of octreotide in the prevention of complication fistula after elective pancreatic resections: a prospective, controlled randomized trial Surgery 117 26–31 Occurrence Handle7809832 Occurrence Handle1:STN:280:DyaK2M7gvVOrsA%3D%3D

    PubMed  CAS  Google Scholar 

  19. H Friess HG Beger U Sulkowski H Becker B Hofbauer HJ Dennler MW Buchler (1995) ArticleTitleRandomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis Br J Surg 82 1270–5 Occurrence Handle7552016 Occurrence Handle1:STN:280:DyaK28%2FjtVCnsg%3D%3D

    PubMed  CAS  Google Scholar 

  20. AM Lowy JE Lee PW Pisters BS Davidson CJ Fenoglio P Stanford et al. (1997) ArticleTitleProspective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease Ann Surg 226 632–41 Occurrence Handle9389397 Occurrence Handle1:STN:280:DyaK1c%2FkvFaltw%3D%3D Occurrence Handle10.1097/00000658-199711000-00008

    Article  PubMed  CAS  Google Scholar 

  21. CJ Yeo JL Cameron KD Lillemoe PK Sauter J Coleman TA Sohn et al. (2000) ArticleTitleDoes prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial Ann Surg 232 419–29 Occurrence Handle10973392 Occurrence Handle1:STN:280:DC%2BD3cvktFKluw%3D%3D Occurrence Handle10.1097/00000658-200009000-00014

    Article  PubMed  CAS  Google Scholar 

  22. M Sarr (2003) ArticleTitleG, for the Pancreatic Surgery Group. The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo controlled trial J Am Coll Surg 196 556–65 Occurrence Handle12691930 Occurrence Handle10.1016/S1072-7515(03)00104-2

    Article  PubMed  Google Scholar 

  23. B Suc S Msika M Piccinini G Fourtanier JM Hay Y Flamant et al. (2004) ArticleTitlethe French Associations for Surgical Research. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial Arch Surg 139 288–94 Occurrence Handle15006886 Occurrence Handle10.1001/archsurg.139.3.288

    Article  PubMed  Google Scholar 

  24. FJ Briceño Delgado P Lopez Cillero S Rufian Peña G Solorzano Peck G Mino Fugarolas C Pera Madrazo (1998) ArticleTitleEstudio prospectivo y randomizado sobre la utilidad del Octreotido en la prevención de complicaciones tras duodeno-pancreatectomía cefálica Rev Esp Enferm Dig 90 687–94 Occurrence Handle9824933

    PubMed  Google Scholar 

  25. A Nakatsuka K Yamaguchi K Chijiiwa M Tanaka (2000) ArticleTitleOctreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage Int Surg 85 124–9 Occurrence Handle11071328 Occurrence Handle1:STN:280:DC%2BD3crht1yhtQ%3D%3D

    PubMed  CAS  Google Scholar 

  26. JR Lange SM Steinberg GM Doherty HN Langstein DE White TH Shawker et al. (1992) ArticleTitleA randomized, prospective trial of postoperative somatostatin analogue in patients with neuroendocrine tumors of the pancreas Surgery 112 1033–7 Occurrence Handle1455306 Occurrence Handle1:STN:280:DyaK3s%2FovVWmsQ%3D%3D

    PubMed  CAS  Google Scholar 

  27. SP Barnett PJ Hodul S Creech J Pickleman GV Arahna (2004) ArticleTitleOctreotide does not prevent postoperative pancreatic fistula or mortality following pancreaticoduodenectomy Am Surg 70 222–6 Occurrence Handle15055845

    PubMed  Google Scholar 

  28. P Hildebrand G Nair S Ketterer (2000) ArticleTitleVapreotide, a long-acting somatostatin analogue, dose dependently inhibits exocrine pancreatic secretion in healthy subjects (abstract) Gastroenterology 118 A415 Occurrence Handle10.1016/S0016-5085(00)83770-1

    Article  Google Scholar 

  29. J Li-Ling M Irving (2001) ArticleTitleSomatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials Br J Surg 88 190–9 Occurrence Handle11167865 Occurrence Handle1:STN:280:DC%2BD3M7kt1WjsA%3D%3D Occurrence Handle10.1046/j.1365-2168.2001.01659.x

    Article  PubMed  CAS  Google Scholar 

  30. SA Jenkins DM Nott JN Baxter (1995) ArticleTitleFluctuations in the secretion of pancreatic enzymes between consecutive doses of octreotide: implications for the management of fistulae Eur J Gastroenterol Hepatol 7 255–8 Occurrence Handle7743308 Occurrence Handle1:STN:280:DyaK2M3mtFyqug%3D%3D

    PubMed  CAS  Google Scholar 

  31. H Friess K Bordihn M Ebert P Malfertheiner T Kemmer HJ Dennler MW Buchler (1994) ArticleTitleInhibition of pancreatic secretion under long-term octreotide treatment in humans Digestion 55 IssueIDsuppl 1 10–5 Occurrence Handle8132133 Occurrence Handle1:CAS:528:DyaK2cXitlKmsLs%3D Occurrence Handle10.1159/000201182

    Article  PubMed  CAS  Google Scholar 

  32. D Ludwig S Terai A Bruning EF Stange (1999) ArticleTitleLong-term haemodynamic effects of octreotide on postprandial splanchnic hyperemia in humans: a placebo-controlled echo-Doppler study Aliment Pharmacol Ther 13 1119–29 Occurrence Handle10468691 Occurrence Handle1:CAS:528:DyaK1MXlvFGnsbw%3D Occurrence Handle10.1046/j.1365-2036.1999.00583.x

    Article  PubMed  CAS  Google Scholar 

  33. H Samnegard G Tyden L Thulin L Friman R Uden (1980) ArticleTitleEffect of somatostatin on splanchnic blood flows in man: angiographic studies Acta Chir Scand Suppl 500 71

    Google Scholar 

  34. T Talme J Ivanoff KG Sundqvist (2004) ArticleTitleSomatostatin is a specific inhibitor of SDF-1alpha-induced T cell infiltration Clin Exp Immunol 135 434–9 Occurrence Handle15008975 Occurrence Handle1:CAS:528:DC%2BD2cXislalsb4%3D Occurrence Handle10.1111/j.1365-2249.2003.02370.x

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA

    Antonio Ramos-De la Medina

  2. Gastroenterology Research Unit (Alfred 2-435), Mayo Clinic College of Medicine, 200 First Street S.W., Rochester, MN, 55902, USA

    Michael G. Sarr

Authors
  1. Antonio Ramos-De la Medina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael G. Sarr
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Medina, AD., Sarr, M. Somatostatin analogues in the prevention of pancreas-related complications after pancreatic resection. J Hepatobiliary Pancreat Surg 13, 190–193 (2006). https://doi.org/10.1007/s00534-005-1033-9

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00534-005-1033-9

Key words

Search

Navigation